2011Medical Journal of Chinese People's HealthRequires access

Comparative analysis of Ziprasidone and Risperidone in the treatment of schizoprenia

Li Jie

Open publisher page 0 citations

Abstract

Objective:To explore the efficacy and safety of Ziprasidone in treatment of schizophrenia.Methods:64 patients with schizophrenia were randomly assigned to Ziprasidone group(n=34) and Resperdone group(n=34),treatment 8 weeks.Positive and negative syndromescale(PANSS)and treatment emergent side effect scale(TESS) were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of Ziprasidone group were 64.7% and 82.4% after 8 weeks,similar to Risperdone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.6% and 85.2%).However,there were no significant differences between two groups.Total incidenceof side effects in Ziprasidone group was significantly lower than that in Risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,wich is as effective as Resperidone and has fewer side effects compared with Risperdone.

About this research paper

What this paper is about

Objective:To explore the efficacy and safety of Ziprasidone in treatment of schizophrenia.Methods:64 patients with schizophrenia were randomly assigned to Ziprasidone group(n=34) and Resperdone group(n=34),treatment 8 weeks.Positive and negative syndromescale(PANSS)and treatment emergent side effect scale(TESS) were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of Ziprasidone group were 64.7% and 82.4% after 8 weeks,similar to Risperdone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.6% and 85.2%).However,there were no significant differences between two groups.Total incidenceof side effects in Ziprasidone group was significantly lower than that in Risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,wich is as effective as Resperidone and has fewer side effects compared with Risperdone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the efficacy and safety of Ziprasidone in treatment of schizophrenia.Methods:64 patients with schizophrenia were randomly assigned to Ziprasidone group(n=34) and Resperdone group(n=34),treatment 8 weeks.Positive and negative syndromescale(PANSS)and treatment emergent side effect scale(TESS) were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of Ziprasidone group were 64.7% and 82.4% after 8 weeks,similar to Risperdone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.6% and 85.2%).However,there were no significant differences between two groups.Total incidenceof side effects in Ziprasidone group was significantly lower than that in Risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,wich is as effective as Resperidone and has fewer side effects compared with Risperdone.

Key concepts: Ziprasidone, Risperidone, Schizophrenia (object-oriented programming), Internal medicine, Side effect (computer science), Medicine, Negative symptom, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative analysis of Ziprasidone and Risperidone in the treatment of schizoprenia — Research Paper | ScholarLens